Takashige Maeyama

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis.

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis.

Journal: Scientific reports

Published: July 19, 2025

Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.

Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.

Journal: BMC pulmonary medicine

Published: May 21, 2025

Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study.

Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study.

Journal: Scientific reports

Published: April 23, 2025

Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

Journal: BMC pulmonary medicine

Published: March 08, 2024

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.

Journal: BMJ open respiratory research

Published: June 01, 2023

Early Recognition and Treatment of Relapsing Polychondritis.

Early Recognition and Treatment of Relapsing Polychondritis.

Journal: Cureus

Published: January 20, 2022

Idiopathic Pulmonary Fibrosis Complicated by Adenocarcinoma and Organizing Pneumonia.

Idiopathic Pulmonary Fibrosis Complicated by Adenocarcinoma and Organizing Pneumonia.

Journal: Cureus

Published: January 03, 2022

A Case of Drug-Induced Interstitial Lung Disease Caused by Epirubicin and Cyclophosphamide Therapy Before Breast Cancer Surgery.

A Case of Drug-Induced Interstitial Lung Disease Caused by Epirubicin and Cyclophosphamide Therapy Before Breast Cancer Surgery.

Journal: Cureus

Published: December 24, 2021

A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy.

A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy.

Journal: Cureus

Published: December 10, 2021

Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease.

Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: December 06, 2021

Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum.

Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum.

Journal: Respiratory medicine case reports

Published: April 27, 2021

A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin.

A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin.

Journal: The American journal of case reports

Published: April 27, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026